Abstract
NVP-BEZ235 is a novel dual PI3K/mTOR inhibitor, currently in phase 1/2 clinical trials, exhibiting clinical efficiency in treatment of numerous malign......
小提示:本篇文献需要登录阅读全文,点击跳转登录